<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>同写意 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-06T20:23:44+08:00</updated>
  <subtitle>一个以新药创制为核心，汇集国内一流研发精英的大型交流与价值分享平台。“同筑技术人生路，写意中国新药魂”是同写意的初衷与愿景。秉承汇集“一线、一流”，讲求“实用、实在、时效”的原则</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>科创板咨询委委员、肿瘤专家李进：未来一二级市场重点要投这个方向 ，Top20药企百分之七八十都跟“肿瘤药”有关</title>
    <updated>2020-12-06T18:33:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-06:/s/P-agZbC78zpx5we9bGuZFg</id>
    <link href="https://mp.weixin.qq.com/s/P-agZbC78zpx5we9bGuZFg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>安进CD19/CD3双特异性抗体新药正式在中国获批</title>
    <updated>2020-12-06T18:33:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-06:/s/eAsumS56Gh7GK2sCsD5T4A</id>
    <link href="https://mp.weixin.qq.com/s/eAsumS56Gh7GK2sCsD5T4A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>跟随性药物：一代新药胜旧药</title>
    <updated>2020-12-06T18:33:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-06:/s/mv7xDNhpVwb_i5lMUsPJvg</id>
    <link href="https://mp.weixin.qq.com/s/mv7xDNhpVwb_i5lMUsPJvg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>年终大盘点​！2020年FDA批准的抗癌新药：十大癌症迎来22款新疗法</title>
    <updated>2020-12-06T18:33:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-06:/s/-Z28w8TTgg6UM83u0tgyJw</id>
    <link href="https://mp.weixin.qq.com/s/-Z28w8TTgg6UM83u0tgyJw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意报告丨探讨境外已上市境内未上市化学药品临床研究</title>
    <updated>2020-12-04T19:49:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/1paR0ejrOUg7WfzqJaF9LQ</id>
    <link href="https://mp.weixin.qq.com/s/1paR0ejrOUg7WfzqJaF9LQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【内有福利】赛业大事记丨赛业百沐小动物手术模型表型分析平台隆重开幕</title>
    <updated>2020-12-04T19:49:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/hfQ1GYUIehK8HI-ClmkCAA</id>
    <link href="https://mp.weixin.qq.com/s/hfQ1GYUIehK8HI-ClmkCAA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>美迪西：肿瘤免疫药效评价适合选用哪些模型？</title>
    <updated>2020-12-04T19:49:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/HYGJuFEFUp86bA1chXMTog</id>
    <link href="https://mp.weixin.qq.com/s/HYGJuFEFUp86bA1chXMTog" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDK4/6：First-in-Class年销50亿美元，恒瑞、贝达、君实争相布局</title>
    <updated>2020-12-04T19:49:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/mMXzlg-t7Gegy2ZC7STsIg</id>
    <link href="https://mp.weixin.qq.com/s/mMXzlg-t7Gegy2ZC7STsIg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>程增江受聘为招商银行特聘专家</title>
    <updated>2020-12-04T19:40:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/vllxlExES7dNQ_d5bfmrYw</id>
    <link href="https://mp.weixin.qq.com/s/vllxlExES7dNQ_d5bfmrYw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球第二款RET抑制剂再批新适应症，有望成为一种广谱抗癌方式</title>
    <updated>2020-12-04T19:40:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/zyEzUh0tJdg4FCNE_pJK5w</id>
    <link href="https://mp.weixin.qq.com/s/zyEzUh0tJdg4FCNE_pJK5w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意发布丨盛世泰科与美迪西PROTAC项目达成战略合作</title>
    <updated>2020-12-04T19:40:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/5dZToJAOlxvsYRkcp5PZFw</id>
    <link href="https://mp.weixin.qq.com/s/5dZToJAOlxvsYRkcp5PZFw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意云课丨第63期：间充质干细胞外泌体——“神奇药囊”的应用</title>
    <updated>2020-12-04T19:40:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/qqxwzrtrigLfxLqrSXY3cw</id>
    <link href="https://mp.weixin.qq.com/s/qqxwzrtrigLfxLqrSXY3cw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意报告︱朱祯平：抗HER2靶点创新生物药的研发</title>
    <updated>2020-12-03T18:05:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/-Sb5UhJaddffSrmleR0a1Q</id>
    <link href="https://mp.weixin.qq.com/s/-Sb5UhJaddffSrmleR0a1Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>美中药源述评：英国批准首款mRNA产品</title>
    <updated>2020-12-03T18:05:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/vv4NC_O5ljeRwSxL0eG1nQ</id>
    <link href="https://mp.weixin.qq.com/s/vv4NC_O5ljeRwSxL0eG1nQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>核心产品获FDA孤儿药认定！廖晓伶解锁靶向髓细胞的新型癌症免疫疗法</title>
    <updated>2020-12-03T18:05:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/U5HxlKeQA607byCN7Y3_9g</id>
    <link href="https://mp.weixin.qq.com/s/U5HxlKeQA607byCN7Y3_9g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>同写意 | 药明直播间：  针对抗体偶联药物的分析能力及策略</title>
    <updated>2020-12-03T18:05:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/rBDP7eQ3jC-oQgHTuDuZtg</id>
    <link href="https://mp.weixin.qq.com/s/rBDP7eQ3jC-oQgHTuDuZtg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>助力新冠疫苗研发的免洗免灭菌药用玻璃内包材</title>
    <updated>2020-12-02T18:15:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/DDW1y9fLgE4ZguV3k8iMLw</id>
    <link href="https://mp.weixin.qq.com/s/DDW1y9fLgE4ZguV3k8iMLw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意发布丨再鼎医药任命Alan Sandler博士为总裁，肿瘤领域全球开发负责人</title>
    <updated>2020-12-02T18:15:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/YbhIbArqFvqwtgphxC6iVw</id>
    <link href="https://mp.weixin.qq.com/s/YbhIbArqFvqwtgphxC6iVw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>会员机构丨济煜医药·突破创新界限，共创人类健康</title>
    <updated>2020-12-02T18:15:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/2oXQ03d0L2JTL2F3HVgbGA</id>
    <link href="https://mp.weixin.qq.com/s/2oXQ03d0L2JTL2F3HVgbGA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>活动推荐丨恺思卓越人才计划——临床研究精英班（第八期）报名开始啦！</title>
    <updated>2020-12-02T18:15:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/j_dMy7s1hU9GbtEHvZd0-Q</id>
    <link href="https://mp.weixin.qq.com/s/j_dMy7s1hU9GbtEHvZd0-Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>